Recent Articles from GlobeNewswire

NEW HOPE, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced financial results for the first quarter ended March 31, 2026, and provided a business update highlighting momentum across the Company’s pivotal-stage programs for Atrioventricular Interval Modulation (“AVIM”) Therapy and Virtue® Sirolimus AngioInfusion™ Balloon (“Virtue SAB”) supported by the Company’s strong balance sheet.

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Upstart Holdings, Inc. (“Upstart” or the “Company”) (NASDAQ: UPST) and certain officers.   The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-02974, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Upstart securities between May 14, 2025 and November 4, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

Strong Revenue Growth Demonstrating Success of Company Strategy

Court allows Sezzle’s core monopolization and restraint of trade claims to proceed

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against LKQ Corporation (“LKQ” or the “Company”) (NASDAQ: LKQ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against SES AI Corporation (“SES AI” or the “Company”) (NYSE: SES).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

The design pays tribute to Sun Country’s Minnesota roots and the customers and employees who shaped its journey

CINCINNATI, May 12, 2026 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, today announced that its Board of Directors declared monthly dividend distributions of $0.1083 per share of the Company’s common stock payable on July 1, 2026 and August 4, 2026 to stockholders of record as of June 15, 2026 and July 15, 2026, respectively.

Next anticipated Revita® clinical data readouts are 1-year data from the REVEAL-1 Cohort in Q2 2026 and 1-year randomized data from the REMAIN-1 Midpoint Cohort in Q3 2026

Announces Retirement of Chief Financial Officer

First quarter 2026 total revenue of $9.7 million, including $6.2 million of core revenue and $3.4 million of SPL Program-related revenue

AUSTIN, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), the world’s largest cloud- and carrier-neutral data center platform, announced today its board of directors has authorized quarterly cash dividends for common and preferred stock for the second quarter of 2026.

REGULATED INFORMATION

Revenue of $66.4 million, Up 4% Year-over-Year, Driven by Strong Wholesale Growth and Benefits from Retail Expansion

BRISBANE, Australia, May 12, 2026 (GLOBE NEWSWIRE) -- North American lithium producer Elevra Lithium Limited (“Elevra” or "Company") (ASX:ELV; NASDAQ:ELVR) is pleased to announce that it has purchased and terminated the spodumene concentrate offtake agreement (“Offtake Agreement”) previously granted to an investment vehicle managed by Waratah Capital Advisors Ltd (“Waratah”) in respect of the Moblan Lithium Project (“Moblan”). Moblan is owned 60% by Elevra and 40% by Investissement Québec.

MALVERN, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the first quarter ended March 31, 2026.

REDWOOD CITY, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of hyperinsulinism (HI), today reported financial results and provided a business update for the three months ended March 31, 2026.

C-BEYOND Phase 3 North American Trial for Treatment of Hepatitis C Virus (HCV) Remains on Track with Topline Results Expected Mid-2026

SOUTH SAN FRANCISCO, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced it awarded inducement grants on May 10, 2026 under BBOT’s 2025 Inducement Plan as a material inducement to the employment of one individual hired by BBOT in March 2026.

ZUG, Switzerland, May 12, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced financial results for the first quarter ended in March 31, 2026, and provided a business update.

MENLO PARK, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will be participating in the upcoming J.P. Morgan Global Technology, Media and Communications Conference on May 19, 2026.

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Datadog, Inc. (NASDAQ:DDOG), the leading AI-powered observability and security platform, today announced that management will present at the following investor conferences:

SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced that Company management will participate in a fireside chat at the H.C. Wainwright 4th Annual BioConnect Investor Conference on Tuesday, May 19, 2026 at 9:30 a.m. ET.

SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (“Gyre”, “Gyre Therapeutics” or the “Company”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company with operations in the United States and China, today announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has accepted its New Drug Application (NDA) for F351 (hydronidone) as a treatment for chronic hepatitis B (CHB)-induced liver fibrosis, which is liver damage resulting from the infection of the hepatitis B virus (HBV). The acceptance comes after the NMPA previously granted priority review status for F351 in March after Gyre submitted the NDA through its majority-owned subsidiary Gyre Pharmaceuticals Co., Ltd. (Gyre Pharmaceuticals). This marks the second major product for which Gyre has submitted an NDA to the NMPA, and is a significant milestone for the Company in the commercialization of a new medication for the treatment of CHB-induced liver fibrosis.

Veteran industry leader appointed to drive the brand’s continued strategic development

WATERTOWN, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases, today announced that the Company will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2026 at 1:35 p.m. ET.

SAN JOSE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced that it will participate in the following upcoming financial conferences during the second quarter of 2026:

Positive pre-BLA meeting with FDA alignment reached on KYSA-8 single-arm trial in stiff person syndrome (SPS); rolling BLA submission initiated

JACKSONVILLE, Fla., May 12, 2026 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) announced that the Company’s Board of Directors approved a $0.14 per share quarterly dividend on the Company’s common stock. The dividend is payable June 15, 2026, to shareholders of record at the close of business May 29, 2026.

WILMINGTON, Del., May 12, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension (“PAH”), today reported financial results for the quarter ended March 31, 2026, and highlighted recent developments.

– Q1 revenue totals $19.8 million– Q1 net loss and adjusted EBITDA came in at $(0.5) million and $3.3 million, respectively– 2026 revenue guidance updated to $95-$100 million; adjusted EBITDA guidance unchanged at $21-$25 million– Paid off an incremental $2.7 million in principal from term loan during Q1– Completed debt refinancing, subsequent to end of Q1, with a $35 million traditional banking facility, resulting in expected $1.5 million in annual interest expense savings– Launched operating efficiency initiatives, subsequent to end of Q1, with expected annualized savings of $3 million, including $1 million in 2026

Positive topline data from Phase 2 HORIZON trial of MZE829 in patients with broad AMKD provide proof-of-concept and support advancement into pivotal trial; additional HORIZON data expected in late 2026 or early 2027

– Company reports record demand for YCANTH® as dispensed applicator units grew to 15,302 in Q1 2026, up 12.1% over the previous quarter and 51.3% year-over-year, and has now exceeded 100,000 dispensed applicator units since launch –

SOUTH SAN FRANCISCO, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biotechnology company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today reported financial results for the first quarter ended March 31, 2026.

Highlights Nominees’ Robust Skillsets and Extensive Experience in Healthcare and Biopharmaceuticals

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced corporate highlights and unaudited financial results for the first quarter of 2026.

DENVER, May 12, 2026 (GLOBE NEWSWIRE) -- Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, today announced that it will release its first quarter 2026 financial results after market close on May 13, 2026.

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Power Solutions International, Inc. (“Power Solutions” or the “Company”) (NASDAQ: PSIX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Alight, Inc. (“Alight” or the “Company”) (NYSE: ALIT).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Gemini Space Station, Inc. (“Gemini” or the “Company”) (NASDAQ: GEMI) and certain officers.   The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-02261, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: (a) Gemini Class A common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company’s initial public offering conducted on or about September 12, 2025 (the “IPO” or “Offering”); and/or Gemini securities between September 12, 2025 and February 17, 2026, both dates inclusive (the “Class Period”).  Plaintiff pursues claims against the Defendants seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 11 and 15 of the Securities Act of 1933 (the “Securities Act”) and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”)

Folsom, NJ, May 12, 2026 (GLOBE NEWSWIRE) -- Media Contact: SJI Media Relations609-561-9000 ext. 4131 media@sjindustries.com

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Grocery Outlet Holding Corp. (“Grocery Outlet” or the “Company”) (NASDAQ: GO).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Hercules Capital, Inc. (“Hercules” or the “Company”) (NYSE: HTGC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

New York, May 12, 2026 (GLOBE NEWSWIRE) -- Inception Growth Acquisition Limited (NASDAQ: IGTA, the “Company”), a publicly traded special purpose acquisition company, announced today that on May 11, 2026, the Company deposited $12,203.33 into the Company’s trust account (the “Trust Account”)  in order to extend the period of time the Company has to complete a business combination for an additional one (1) month period, from May 13, 2026 to June 13, 2026. The purpose of the extension is to provide additional time for the Company to complete a business combination.

Built by two working moms navigating the realities of caregiving, POP Care introduces a new category for organization and support called Lived-In Health™

Program will help to expand resources to improve completion rates

HOUSTON, May 12, 2026 (GLOBE NEWSWIRE) -- Koil Energy Solutions, Inc. (OTCQB: KLNG), a specialist in deepwater energy production and distribution equipment and services, announced today that it will report its first quarter 2026 results on Friday, May 15, 2026, before the market opens.

Mesquite, NV, May 12, 2026 (GLOBE NEWSWIRE) -- MESQUITE, Nev., May 12, 2026 (GLOBE NEWSWIRE) -- Nuclear Diamond Batteries, Inc. (OTCID: NDBI) (“NDBI” or the “Company”), a developer of next-generation nuclear diamond battery technologies through its majority-owned subsidiary AtomiQ, Inc., today announced that the United States Patent and Trademark Office (“USPTO”) has issued a Notice of Allowance for 19 claims under U.S. patent application No. 17/928,967 covering a specialized high-porosity electrode architecture designed for advanced nuclear diamond battery systems.

Backed by Kleiner Perkins and Founders Fund, Roadrunner launches its AI-native quoting platform to replace legacy CPQ with a new category: PQA — Prompt, Quote, Approve

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) --

Oklahoma City's premier resort destination debuts The Boardwalk, completes its dining lineup, and brings an all-new season of programming for 2026

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- As the sports industry undergoes a rapid transformation driven by name, image, and likeness (NIL) opportunities, athlete-driven business ventures, and increasingly complex commercial relationships, a timely second edition of Sports Law: A Practical Guide to Protecting the Interests of Athletes (Second Edition) is now available from PLI Press.

Send Volume to Countries Celebrating Mother’s Day Jumps 49% Year-over-Year

Sports.com Featured in Industry Discussions on Football Media, Audience Growth and Monetization

Vicki Worden, CAE, led GBI to achieve tremendous growth during her 11-year tenure; The Honorable Stephen T. Ayers, FAIA, appointed as GBI Interim CEO

Shoreview, MN, May 12, 2026 (GLOBE NEWSWIRE) -- TSI Incorporated announces that TSI Link™ for Respiratory Protection won the highly respected Occupational Health and Safety Industrial Hygiene Award in the category of Respiratory Protection: Fit Testing. The award honors outstanding product development achievements for health and safety manufacturers; this recognition highlights the solution's ability to help enterprises manage risk, support regulatory compliance, and streamline workplace safety programs across diverse industries.

PRESS RELEASE

A wildly saucy desert escape where fans can win the keys to Habit Ranch for one unforgettable weekend

Folsom, NJ, May 12, 2026 (GLOBE NEWSWIRE) -- Media Contact: SJI Media Relations609-561-9000 ext. 4131 media@sjindustries.com

Sutter Health to Serve as Official Healthcare and Jersey Patch Partner to Advance Community Health and Clinical Excellence

Washington, D.C., May 12, 2026 (GLOBE NEWSWIRE) -- Archetype Data, a leading provider of B2B, B2C, and B2B2C data solutions, and Aristotle, a recognized leader in political data and voter intelligence, today announced a strategic partnership to deliver advanced, digital-ready audience segments for political, advocacy, and issue-based campaigns. 

According to FXStreet data, the gold price stood at INR 14,359 per gram, a rise compared with INR 14,283.83 it cost on Thursday, 7th May. Taking advantage of a series of such opportunities could mean massive returns in the modern financial market. However, with the fast-moving digital market, how can a retail trader maintain consistent success in trading executions?

IRVINE, Calif, May 12, 2026 (GLOBE NEWSWIRE) --  Linkhome Holdings Inc. (the “Company” or “Linkhome”) (Nasdaq: LHAI), an AI-driven real estate and fintech platform, today announced that it has entered into a definitive agreement to acquire 100% of the equity interests of Constant Investments, Inc., doing business as Mortgage One Group, a full-service mortgage lending company with operations across multiple U.S. states. Subject to customary closing conditions, the transaction is subject to customary closing conditions, and is expected to close on or before July 1,2026.

HUNTSVILLE, Ala., May 12, 2026 (GLOBE NEWSWIRE) -- On April 24, 2026, the Annual General Meeting of Hexagon AB (“Hexagon”) resolved to distribute all shares in its wholly-owned subsidiary Octave Intelligence plc (“Octave”) to Hexagon’s shareholders. Octave’s Swedish depository receipts (“SDRs”) will be listed on Nasdaq Stockholm and Octave’s class B ordinary shares will be listed on the Nasdaq Stock Market in New York (“Nasdaq New York”).

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Titan Partners, a division of American Capital Partners ("Titan Partners" or "Titan"), is pleased to announce the appointments of Scott Buck, Kyle Bauser, Ph.D., and Adam Kelsey, CFA, significantly broadening its equity research platform across technology, healthcare, and energy, power & infrastructure. Collectively, Mr. Buck, Dr. Bauser, and Mr. Kelsey bring more than 40 years of equity research experience across the middle market, with proven track records of identifying emerging themes and companies ahead of broader market adoption. All three bring deep sector expertise in addition to long-standing institutional relationships cultivated over years of industry coverage. Together, they strengthen Titan's research division, build on the platform's capabilities, and reflect continued investment in sector-focused research that drives value for both institutional investors and corporate issuers.

Cate Blanchett co-founds new public benefit nonprofit providing a human consent framework for AI’s use of creative work, name, image and likeness.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

1,103 creators. 20,000+ pieces of content. 236 million views. The Creator Voyage is rewriting the travel marketing playbook.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

With new leadership team in place, the firm is well positioned for strategic growth led by innovation and accountability

WARREN, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that it has entered into a securities purchase agreement for a private investment in public equity (the “PIPE”) financing with existing investor The Patel Family, LLP for gross proceeds of $3 million. The Company intends to use the proceeds from the PIPE financing to support ongoing operations, advance strategic growth initiatives, and for general corporate purposes.

From Quantitative Strategies to Sentiment Analysis—Master the Markets with the Most Advanced Algorithmic Trading Ecosystem.